biOasis Technologies Inc (TSE:BTI)
TSXV:BTI
Holding TSE:BTI?
Track your performance easily

biOasis Technologies (BTI) Stock Price & Analysis

8 Followers

BTI Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

22.61%0.00%0.00%77.39%
22.61%
Insiders
0.00% Other Institutional Investors
77.39% Public Companies and
Individual Investors

BTI FAQ

What was biOasis Technologies Inc’s price range in the past 12 months?
biOasis Technologies Inc lowest stock price was <C$0.01 and its highest was C$0.01 in the past 12 months.
    What is biOasis Technologies Inc’s market cap?
    Currently, no data Available
    When is biOasis Technologies Inc’s upcoming earnings report date?
    biOasis Technologies Inc’s upcoming earnings report date is Jan 18, 2024 which is 295 days ago.
      How were biOasis Technologies Inc’s earnings last quarter?
      Currently, no data Available
      Is biOasis Technologies Inc overvalued?
      According to Wall Street analysts biOasis Technologies Inc’s price is currently same. Get more investment ideas with TipRanks Premium
        Does biOasis Technologies Inc pay dividends?
        biOasis Technologies Inc does not currently pay dividends.
        What is biOasis Technologies Inc’s EPS estimate?
        biOasis Technologies Inc’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does biOasis Technologies Inc have?
        biOasis Technologies Inc has 79,414,020 shares outstanding.
          What happened to biOasis Technologies Inc’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of biOasis Technologies Inc?
          Currently, no hedge funds are holding shares in TSE:BTI
          ---

          biOasis Technologies Stock Smart Score

          Company Description

          biOasis Technologies Inc

          Bioasis Technologies Inc is a development stage biopharmaceutical company. It is engaged in the research and development of products for the diagnosis and treatment of neurological disease and disorders. The company has worked on blood-brain barrier program and studies disorders in the brain. The company's xB3 program describes its proprietary carrier, p97, and components thereof, to deliver therapeutics across the blood-brain barrier. Its source of revenue involves the research and license revenue.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Willow Biosciences Inc
          Biome Grow Inc
          BriaCell Therapeutics
          Alpha Cognition Inc
          Popular Stocks
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis